|
|
 |
|
Viewing report
|
|
|
|
Sepsis Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc, Aug 2011, Pages: 188
This report analyzes the worldwide markets for Sepsis Therapeutics in US$ Million. Analytics refer to sales of drugs used in the direct treatment of severe sepsis/septic shock. The report provides separate comprehensive analytics for the US, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.
The report profiles 33 companies including many key and niche players such as
- Agennix AG (Germany)
- AstraZeneca Plc (UK)
- Artisan Pharma (US)
- Atox Bio, Inc. (US)
- CytoGenix, Inc. (US)
- Chong Kun Dang Pharmaceutical Corporation (Korea)
- Daiichi-Sankyo Company, Ltd. (Japan)
- Endacea, Inc. (US)
- Eli Lilly and Company (US)
- Medinox, Inc.
- NexBio, Inc. (US)
Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
|
|
|
|
